Supported Reaching + Abduction Loading for Stroke
(PRALINE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people who have had a recent stroke improve arm movement. After a stroke, some individuals struggle with reaching outward due to a movement issue called "flexion synergy." The trial will test two therapies: one involves practicing reaching with added weight (abduction loading), and the other involves reaching with support (supported reaching). Ideal candidates for this trial are those who have experienced a stroke affecting one side of the brain within the last 90 days and have mild language or attention issues. Participants will continue their usual therapies while trying one of these new methods. As an unphased trial, this study offers a unique opportunity to explore innovative therapies that could enhance recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that progressive abduction loading therapy is generally safe for stroke patients, with studies identifying no specific safety concerns. This therapy includes exercises to help regain arm movement after a stroke, aiming to improve the ability to reach out by practicing with added weight. Patients typically handle this therapy well.
For the supported reaching approach, no safety issues have been reported. This method involves practicing reaching movements with support to enhance arm function. Both approaches focus on improving movement and are considered safe based on previous studies.12345Why are researchers excited about this trial?
Researchers are excited about the Supported Reaching + Abduction Loading approach for stroke rehabilitation because it focuses on innovative movement techniques that differ from traditional therapies. Unlike standard rehabilitation methods that often involve repetitive exercises to regain strength and coordination, this approach incorporates abduction loading and supported reaching, which specifically target muscle activation and control during reaching tasks. By challenging the muscles in new ways, these techniques could potentially enhance motor recovery and offer more precise improvements in arm function for stroke patients.
What evidence suggests that this trial's treatments could be effective for minimizing flexion synergy after stroke?
This trial will compare two techniques for improving arm movement after a stroke: abduction loading and supported reaching. Research has shown that abduction loading, which participants in one arm of this trial will practice, can enhance arm movement by improving control of arm joints, making it easier to reach out. Early research discovered that abduction loading during reaching exercises boosts arm function, especially for those with long-term stroke conditions.
Participants in another arm of this trial will practice supported reaching, which has been shown to increase muscle activity in the arm. This method enhances arm muscle function by supporting the arm against gravity as it moves. Both techniques aim to improve movement and strength in the arms, aiding recovery after a stroke.12567Who Is on the Research Team?
Michael D Ellis, PT, DPT
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-85 who've had a stroke within the last 90 days, can consent to participate, and have mild-to-moderate difficulty with language. They should have weakness on one side of their body but be able to follow simple commands with their unaffected arm. People with pre-existing disabilities in their arms, certain brain lesions, medical conditions that limit movement assessments, chronic neurological issues other than stroke, or pain that affects movement cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
In-patient Rehabilitation
Participants receive experimental or comparison group therapy as adjuvant to regular in-patient therapy. Sessions are conducted 5 days per week.
Day Rehabilitation
Participants continue to receive the same study intervention 3 days per week during day-rehabilitation.
Follow-up
Participants are monitored for safety and effectiveness after treatment with evaluations bimonthly until 12 months post-baseline.
What Are the Treatments Tested in This Trial?
Interventions
- Abduction Loading
- Supported Reaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Marianjoy Rehabilitation Hospital & Clinics
Collaborator
Shirley Ryan AbilityLab
Collaborator